{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:35:08Z","timestamp":1775662508976,"version":"3.50.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T00:00:00Z","timestamp":1179360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2007,9,17]]},"DOI":"10.1007\/s11064-007-9360-7","type":"journal-article","created":{"date-parts":[[2007,5,16]],"date-time":"2007-05-16T19:32:03Z","timestamp":1179343923000},"page":"1640-1645","source":"Crossref","is-referenced-by-count":146,"title":["Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease"],"prefix":"10.1007","volume":"32","author":[{"given":"Rudy J.","family":"Castellani","sequence":"first","affiliation":[]},{"given":"Paula I.","family":"Moreira","sequence":"additional","affiliation":[]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Jon","family":"Dobson","sequence":"additional","affiliation":[]},{"given":"George","family":"Perry","sequence":"additional","affiliation":[]},{"given":"Mark A.","family":"Smith","sequence":"additional","affiliation":[]},{"given":"Xiongwei","family":"Zhu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,5,17]]},"reference":[{"key":"9360_CR1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2174\/0929867053764644","volume":"12","author":"MW Marlatt","year":"2005","unstructured":"Marlatt MW, Webber KM, Moreira PI et al (2005) Therapeutic opportunities in Alzheimer disease: one for all or all for one? Curr Med Chem 12:1137\u20131147","journal-title":"Curr Med Chem"},{"key":"9360_CR2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-006-0071-y","volume":"111","author":"RJ Castellani","year":"2006","unstructured":"Castellani RJ, Lee HG, Zhu X et al (2006) Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. Acta Neuropathol (Berl) 111:503\u2013509","journal-title":"Acta Neuropathol (Berl)"},{"key":"9360_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbadis.2006.12.004","volume":"1772","author":"J Woods","year":"2007","unstructured":"Woods J, Snape M, Smith MA (2007) The cell cycle hypothesis of Alzheimer\u2019s disease: suggestions for drug development. Biochim Biophys Acta 1772:503\u2013508","journal-title":"Biochim Biophys Acta"},{"key":"9360_CR4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0887-8994(01)00260-0","volume":"25","author":"TA Rouault","year":"2001","unstructured":"Rouault TA (2001) Systemic iron metabolism: a review and implications for brain iron metabolism. Pediatr Neurol 25:130\u2013137","journal-title":"Pediatr Neurol"},{"key":"9360_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/91036","volume":"28","author":"TA Rouault","year":"2001","unstructured":"Rouault TA (2001) Iron on the brain. Nat Genet 28:299\u2013300","journal-title":"Nat Genet"},{"key":"9360_CR6","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/hmg\/10.20.2181","volume":"10","author":"CN Roy","year":"2001","unstructured":"Roy CN, Andrews NC (2001) Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. Hum Mol Genet 10:2181\u20132186","journal-title":"Hum Mol Genet"},{"key":"9360_CR7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/(SICI)1096-9861(19961125)375:4<675::AID-CNE8>3.0.CO;2-Z","volume":"375","author":"T Moos","year":"1996","unstructured":"Moos T (1996) Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J Comp Neurol 375:675\u2013692","journal-title":"J Comp Neurol"},{"key":"9360_CR8","first-page":"1574","volume":"142","author":"T Kawamata","year":"1993","unstructured":"Kawamata T, Tooyama I, Yamada T et al (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol 142:1574\u20131585","journal-title":"Am J Pathol"},{"key":"9360_CR9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0006-8993(94)90202-X","volume":"650","author":"B Leveugle","year":"1994","unstructured":"Leveugle B, Spik G, Perl DP et al (1994) The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res 650:20\u201331","journal-title":"Brain Res"},{"key":"9360_CR10","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1074\/jbc.275.6.4305","volume":"275","author":"BN Patel","year":"2000","unstructured":"Patel BN, Dunn RJ, David S (2000) Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem 275:4305\u20134310","journal-title":"J Biol Chem"},{"key":"9360_CR11","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/hmg\/5.12.1989","volume":"5","author":"LW Klomp","year":"1996","unstructured":"Klomp LW, Gitlin JD (1996) Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet 5:1989\u20131996","journal-title":"Hum Mol Genet"},{"key":"9360_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(92)91652-U","volume":"592","author":"A Crowe","year":"1992","unstructured":"Crowe A, Morgan EH (1992) Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res 592:8\u201316","journal-title":"Brain Res"},{"key":"9360_CR13","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1073\/pnas.92.26.12115","volume":"92","author":"BH Bowman","year":"1995","unstructured":"Bowman BH, Jansen L, Yang F et al (1995) Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles. Proc Natl Acad Sci USA 92:12115\u201312119","journal-title":"Proc Natl Acad Sci USA"},{"key":"9360_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0098-2997(00)00006-6","volume":"22","author":"PT Lieu","year":"2001","unstructured":"Lieu PT, Heiskala M, Peterson PA et al (2001) The roles of iron in health and disease. Mol Aspects Med 22:1\u201387","journal-title":"Mol Aspects Med"},{"key":"9360_CR15","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1046\/j.1471-4159.2000.0752583.x","volume":"75","author":"KL Double","year":"2000","unstructured":"Double KL, Zecca L, Costi P et al (2000) Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins. J Neurochem 75:2583\u20132589","journal-title":"J Neurochem"},{"key":"9360_CR16","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1073\/pnas.93.16.8175","volume":"93","author":"MW Hentze","year":"1996","unstructured":"Hentze MW, Kuhn LC (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93:8175\u20138182","journal-title":"Proc Natl Acad Sci USA"},{"key":"9360_CR17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0887-8994(01)00303-4","volume":"25","author":"JR Connor","year":"2001","unstructured":"Connor JR, Menzies SL, Burdo JR et al (2001) Iron and iron management proteins in neurobiology. Pediatr Neurol 25:118\u2013129","journal-title":"Pediatr Neurol"},{"key":"9360_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jnr.10177","volume":"68","author":"V Calabrese","year":"2002","unstructured":"Calabrese V, Scapagnini G, Ravagna A et al (2002) Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant\/antioxidant balance and stress tolerance. J Neurosci Res 68:65\u201375","journal-title":"J Neurosci Res"},{"key":"9360_CR19","first-page":"573","volume":"46","author":"MD Maines","year":"2000","unstructured":"Maines MD (2000) The heme oxygenase system and its functions in the brain. Cell Mol Biol (Noisy-le-grand) 46:573\u2013585","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"9360_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/exnr.1997.6750","volume":"150","author":"DL Marcus","year":"1998","unstructured":"Marcus DL, Thomas C, Rodriguez C et al (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer\u2019s disease. Exp Neurol 150:40\u201344","journal-title":"Exp Neurol"},{"key":"9360_CR21","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","volume":"68","author":"LM Sayre","year":"1997","unstructured":"Sayre LM, Zelasko DA, Harris PL et al (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer\u2019s disease. J Neurochem 68:2092\u20132097","journal-title":"J Neurochem"},{"key":"9360_CR22","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1523\/JNEUROSCI.17-08-02653.1997","volume":"17","author":"MA Smith","year":"1997","unstructured":"Smith MA, Richey Harris PL, Sayre LM et al (1997) Widespread peroxynitrite-mediated damage in Alzheimer\u2019s disease. J Neurosci 17:2653\u20132657","journal-title":"J Neurosci"},{"key":"9360_CR23","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","volume":"91","author":"MA Smith","year":"1994","unstructured":"Smith MA, Taneda S, Richey PL et al (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710\u20135714","journal-title":"Proc Natl Acad Sci USA"},{"key":"9360_CR24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/382120b0","volume":"382","author":"MA Smith","year":"1996","unstructured":"Smith MA, Perry G, Richey PL et al (1996) Oxidative damage in Alzheimer\u2019s. Nature 382:120\u2013121","journal-title":"Nature"},{"key":"9360_CR25","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","volume":"94","author":"MA Smith","year":"1997","unstructured":"Smith MA, Harris PL, Sayre LM et al (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94:9866\u20139868","journal-title":"Proc Natl Acad Sci USA"},{"key":"9360_CR26","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","volume":"19","author":"A Nunomura","year":"1999","unstructured":"Nunomura A, Perry G, Pappolla MA et al (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease. J Neurosci 19:1959\u20131964","journal-title":"J Neurosci"},{"key":"9360_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0304-3940(94)11787-J","volume":"195","author":"Y Zhou","year":"1995","unstructured":"Zhou Y, Richardson JS, Mombourquette MJ et al (1995) Free radical formation in autopsy samples of Alzheimer and control cortex. Neurosci Lett 195:89\u201392","journal-title":"Neurosci Lett"},{"key":"9360_CR28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-4159.1986.tb00615.x","volume":"46","author":"RN Martins","year":"1986","unstructured":"Martins RN, Harper CG, Stokes GB et al (1986) Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer\u2019s disease may reflect oxidative stress. J Neurochem 46:1042\u20131045","journal-title":"J Neurochem"},{"key":"9360_CR29","first-page":"621","volume":"140","author":"MA Pappolla","year":"1992","unstructured":"Pappolla MA, Omar RA, Kim KS et al (1992) Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer\u2019s disease. Am J Pathol 140:621\u2013628","journal-title":"Am J Pathol"},{"key":"9360_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","volume":"158","author":"MA Lovell","year":"1998","unstructured":"Lovell MA, Robertson JD, Teesdale WJ et al (1998) Copper, iron and zinc in Alzheimer\u2019s disease senile plaques. J Neurol Sci 158:47\u201352","journal-title":"J Neurol Sci"},{"key":"9360_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/exnr.1995.1062","volume":"135","author":"ED Hall","year":"1995","unstructured":"Hall ED, Oostveen JA, Dunn E et al (1995) Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 135:17\u201327","journal-title":"Exp Neurol"},{"key":"9360_CR32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-4580(00)00119-6","volume":"21","author":"J Shi","year":"2000","unstructured":"Shi J, Perry G, Smith MA et al (2000) Vascular abnormalities: the insidious pathogenesis of Alzheimer\u2019s disease. Neurobiol Aging 21:357\u2013361","journal-title":"Neurobiol Aging"},{"key":"9360_CR33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3940(91)90019-P","volume":"125","author":"K Abe","year":"1991","unstructured":"Abe K, St George-Hyslop PH, Tanzi RE et al (1991) Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells. Neurosci Lett 125:169\u2013171","journal-title":"Neurosci Lett"},{"key":"9360_CR34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00294806","volume":"90","author":"K Jendroska","year":"1995","unstructured":"Jendroska K, Poewe W, Daniel SE et al (1995) Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol (Berl) 90:461\u2013466","journal-title":"Acta Neuropathol (Berl)"},{"key":"9360_CR35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1089\/neu.1998.15.993","volume":"15","author":"N Murakami","year":"1998","unstructured":"Murakami N, Yamaki T, Iwamoto Y et al (1998) Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J Neurotrauma 15:993\u20131003","journal-title":"J Neurotrauma"},{"key":"9360_CR36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-8993(97)00827-5","volume":"772","author":"J Shi","year":"1997","unstructured":"Shi J, Xiang Y, Simpkins JW (1997) Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells. Brain Res 772:247\u2013251","journal-title":"Brain Res"},{"key":"9360_CR37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0736-5748(98)00082-3","volume":"16","author":"MP Mattson","year":"1998","unstructured":"Mattson MP, Pedersen WA (1998) Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer\u2019s disease. Int J Dev Neurosci 16:737\u2013753","journal-title":"Int J Dev Neurosci"},{"key":"9360_CR38","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1016\/S0021-9258(17)36875-8","volume":"269","author":"D Gabuzda","year":"1994","unstructured":"Gabuzda D, Busciglio J, Chen LB et al (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269:13623\u201313628","journal-title":"J Biol Chem"},{"key":"9360_CR39","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1021\/bi000169p","volume":"39","author":"H Misonou","year":"2000","unstructured":"Misonou H, Morishima-Kawashima M, Ihara Y (2000) Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry (Mosc) 39:6951\u20136959","journal-title":"Biochemistry (Mosc)"},{"key":"9360_CR40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1600-079X.2001.310406.x","volume":"31","author":"G Olivieri","year":"2001","unstructured":"Olivieri G, Hess C, Savaskan E et al (2001) Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased beta-amyloid secretion. J Pineal Res 31:320\u2013325","journal-title":"J Pineal Res"},{"key":"9360_CR41","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1074\/jbc.271.17.10169","volume":"271","author":"PH Frederikse","year":"1996","unstructured":"Frederikse PH, Garland D, Zigler JS Jr et al (1996) Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. J Biol Chem 271:10169\u201310174","journal-title":"J Biol Chem"},{"key":"9360_CR42","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1006\/bbrc.2000.2164","volume":"268","author":"D Paola","year":"2000","unstructured":"Paola D, Domenicotti C, Nitti M et al (2000) Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun 268:642\u2013646","journal-title":"Biochem Biophys Res Commun"},{"key":"9360_CR43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","volume":"75","author":"CS Atwood","year":"2000","unstructured":"Atwood CS, Scarpa RC, Huang X et al (2000) Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1\u201342. J Neurochem 75:1219\u20131233","journal-title":"J Neurochem"},{"key":"9360_CR44","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1074\/jbc.273.21.12817","volume":"273","author":"CS Atwood","year":"1998","unstructured":"Atwood CS, Moir RD, Huang X et al (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273:12817\u201312826","journal-title":"J Biol Chem"},{"key":"9360_CR45","doi-asserted-by":"crossref","first-page":"20466","DOI":"10.1074\/jbc.M100175200","volume":"276","author":"CC Curtain","year":"2001","unstructured":"Curtain CC, Ali F, Volitakis I et al (2001) Alzheimer\u2019s disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 276:20466\u201320473","journal-title":"J Biol Chem"},{"key":"9360_CR46","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/bi990438f","volume":"38","author":"X Huang","year":"1999","unstructured":"Huang X, Atwood CS, Hartshorn MA et al (1999) The A beta peptide of Alzheimer\u2019s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry (Mosc) 38:7609\u20137616","journal-title":"Biochemistry (Mosc)"},{"key":"9360_CR47","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.1074\/jbc.274.14.9392","volume":"274","author":"SI Dikalov","year":"1999","unstructured":"Dikalov SI, Vitek MP, Maples KR et al (1999) Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J Biol Chem 274:9392\u20139399","journal-title":"J Biol Chem"},{"key":"9360_CR48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(05)72173-5","volume":"355","author":"G Perry","year":"2000","unstructured":"Perry G, Nunomura A, Raina AK et al (2000) Amyloid-beta junkies. Lancet 355:757","journal-title":"Lancet"},{"key":"9360_CR49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.2000.tb05557.x","volume":"924","author":"MA Smith","year":"2000","unstructured":"Smith MA, Joseph JA, Perry G (2000) Arson. Tracking the culprit in Alzheimer\u2019s disease. Ann NY Acad Sci 924:35\u201338","journal-title":"Ann NY Acad Sci"},{"key":"9360_CR50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0197-4580(00)00211-6","volume":"22","author":"J Joseph","year":"2001","unstructured":"Joseph J, Shukitt-Hale B, Denisova NA et al (2001) Copernicus revisited: amyloid beta in Alzheimer\u2019s disease. Neurobiol Aging 22:131\u2013146","journal-title":"Neurobiol Aging"},{"key":"9360_CR51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0891-5849(00)00494-9","volume":"30","author":"CA Rottkamp","year":"2001","unstructured":"Rottkamp CA, Raina AK, Zhu X et al (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med 30:447\u2013450","journal-title":"Free Radic Biol Med"},{"key":"9360_CR52","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0196-9781(02)00069-4","volume":"23","author":"CA Rottkamp","year":"2002","unstructured":"Rottkamp CA, Atwood CS, Joseph JA et al (2002) The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease. Peptides 23:1333\u20131341","journal-title":"Peptides"},{"key":"9360_CR53","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/00001756-199705260-00033","volume":"8","author":"KM Cullen","year":"1997","unstructured":"Cullen KM (1997) Perivascular astrocytes within Alzheimer\u2019s disease plaques. Neuroreport 8:1961\u20131966","journal-title":"Neuroreport"},{"key":"9360_CR54","first-page":"1","volume-title":"Cytokines and inflammation","author":"CJ Dunn","year":"1991","unstructured":"Dunn CJ (1991) Cytokines as mediators of chronic inflammatory disease. In: Kimball ES (ed) Cytokines and inflammation. CRC, Boca Raton, FL, pp 1\u201333"},{"key":"9360_CR55","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/00001756-199806220-00003","volume":"9","author":"T Yoshida","year":"1998","unstructured":"Yoshida T, Tanaka M, Sotomatsu A et al (1998) Activated microglia cause iron-dependent lipid peroxidation in the presence of ferritin. Neuroreport 9:1929\u20131933","journal-title":"Neuroreport"},{"key":"9360_CR56","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.1994.63030980.x","volume":"63","author":"ED Cadman","year":"1994","unstructured":"Cadman ED, Witte DG, Lee CM (1994) Regulation of the release of interleukin-6 from human astrocytoma cells. J Neurochem 63:980\u2013987","journal-title":"J Neurochem"},{"key":"9360_CR57","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1471-4159.2000.0740270.x","volume":"74","author":"LM Sayre","year":"2000","unstructured":"Sayre LM, Perry G, Harris PL et al (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease: a central role for bound transition metals. J Neurochem 74:270\u2013279","journal-title":"J Neurochem"},{"key":"9360_CR58","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1523\/JNEUROSCI.23-12-04913.2003","volume":"23","author":"X Shan","year":"2003","unstructured":"Shan X, Tashiro H, Lin CL (2003) The identification and characterization of oxidized RNAs in Alzheimer\u2019s disease. J Neurosci 23:4913\u20134921","journal-title":"J Neurosci"},{"key":"9360_CR59","doi-asserted-by":"crossref","first-page":"20978","DOI":"10.1074\/jbc.M500526200","volume":"280","author":"K Honda","year":"2005","unstructured":"Honda K, Smith MA, Zhu X et al (2005) Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem 280:20978\u201320986","journal-title":"J Biol Chem"},{"key":"9360_CR60","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai K, Aliev G, Nunomura A et al (2001) Mitochondrial abnormalities in Alzheimer\u2019s disease. J Neurosci 21:3017\u20133023","journal-title":"J Neurosci"},{"key":"9360_CR61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1098\/rsif.2004.0011","volume":"2","author":"A Mikhaylova","year":"2005","unstructured":"Mikhaylova A, Davidson M, Toastmann H et al (2005) Detection, identification and mapping of iron anomalies in brain tissue using X-ray absorption spectroscopy. J R Soc Interface\/R Soc 2:33\u201337","journal-title":"J R Soc Interface\/R Soc"},{"key":"9360_CR62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JAD-2005-7401","volume":"7","author":"JF Collingwood","year":"2005","unstructured":"Collingwood JF, Mikhaylova A, Davidson M et al (2005) In situ characterization and mapping of iron compounds in Alzheimer\u2019s disease tissue. J Alzheimers Dis 7:267\u2013272","journal-title":"J Alzheimers Dis"},{"key":"9360_CR63","first-page":"54","volume":"17","author":"JF Collingwood","year":"2005","unstructured":"Collingwood JF, Mikhaylova A, Davidson MR et al (2005) High-resolution x-ray absorption spectroscopy studies of metal compounds in neurodegenerative brain tissue. J Phys: Conf Ser 17:54\u201360","journal-title":"J Phys: Conf Ser"},{"key":"9360_CR64","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0361-9230(95)02132-9","volume":"39","author":"J Dobson","year":"1996","unstructured":"Dobson J, Grassi P (1996) Magnetic properties of human hippocampal tissue\u2014evaluation of artefact and contamination sources. Brain Res Bull 39:255\u2013259","journal-title":"Brain Res Bull"},{"key":"9360_CR65","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0304-4165(98)00160-3","volume":"1426","author":"PP Schultheiss-Grassi","year":"1999","unstructured":"Schultheiss-Grassi PP, Wessiken R, Dobson J (1999) TEM investigations of biogenic magnetite extracted from the human hippocampus. Biochim Biophys Acta 1426:212\u2013216","journal-title":"Biochim Biophys Acta"},{"key":"9360_CR66","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1073\/pnas.89.16.7683","volume":"89","author":"JL Kirschvink","year":"1992","unstructured":"Kirschvink JL, Kobayashi-Kirschvink A, Woodford BJ (1992) Magnetite biomineralization in the human brain. Proc Natl Acad Sci USA 89:7683\u20137687","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"9360_CR67","first-page":"S62","volume":"270","author":"D Hautot","year":"2003","unstructured":"Hautot D, Pankhurst QA, Khan N et al (2003) Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer\u2019s disease brain tissue. Proceedings 270(Suppl 1):S62\u2013S64","journal-title":"Proceedings"},{"key":"9360_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(01)02386-9","volume":"496","author":"J Dobson","year":"2001","unstructured":"Dobson J (2001) Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 496:1\u20135","journal-title":"FEBS Lett"},{"key":"9360_CR69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1196\/annals.1306.016","volume":"1012","author":"J Dobson","year":"2004","unstructured":"Dobson J (2004) Magnetic iron compounds in neurological disorders. Ann NY Acad Sci 1012:183\u2013192","journal-title":"Ann NY Acad Sci"},{"key":"9360_CR70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00268979809483134","volume":"95","author":"CR Timmel","year":"1998","unstructured":"Timmel CR, Till U, Brocklehurst B et al (1998) Effects of weak magnetic fields on free radical recombination reactions. Mol Phys 95:71\u201389","journal-title":"Mol Phys"},{"key":"9360_CR71","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1751-1097.1997.tb01921.x","volume":"65","author":"JC Scaiano","year":"1997","unstructured":"Scaiano JC, Monahan S, Renaud J (1997) Dramatic effect of magnetite particles on the dynamics of photogenerated free radicals. Photochem Photobiol 65:759\u2013762","journal-title":"Photochem Photobiol"},{"key":"9360_CR72","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0197-4580(02)00120-3","volume":"23","author":"AI Bush","year":"2002","unstructured":"Bush AI (2002) Metal complexing agents as therapies for Alzheimer\u2019s disease. Neurobiol Aging 23:1031\u20131038","journal-title":"Neurobiol Aging"},{"key":"9360_CR73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2003.09.005","volume":"46","author":"DB Shachar","year":"2004","unstructured":"Shachar DB, Kahana N, Kampel V et al (2004) Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology 46:254\u2013263","journal-title":"Neuropharmacology"},{"key":"9360_CR74","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neurobiolaging.2006.02.005","volume":"28","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis G, Tishler TA, Lu PH et al (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28:414\u2013423","journal-title":"Neurobiol Aging"},{"key":"9360_CR75","doi-asserted-by":"crossref","first-page":"10041","DOI":"10.1523\/JNEUROSCI.2588-05.2005","volume":"25","author":"CR Jack Jr","year":"2005","unstructured":"Jack CR Jr, Wengenack TM, Reyes DA et al (2005) In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer\u2019s transgenic mice. J Neurosci 25:10041\u201310048","journal-title":"J Neurosci"},{"key":"9360_CR76","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A et al (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60:1685\u20131691","journal-title":"Arch Neurol"},{"key":"9360_CR77","first-page":"793","volume":"145","author":"DR McLachlan","year":"1991","unstructured":"McLachlan DR, Kruck TP, Lukiw WJ et al (1991) Would decreased aluminum ingestion reduce the incidence of Alzheimer\u2019s disease? CMAJ 145:793\u2013804","journal-title":"CMAJ"},{"key":"9360_CR78","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbadis.2005.06.006","volume":"1741","author":"G Liu","year":"2005","unstructured":"Liu G, Garrett MR, Men P et al (2005) Nanoparticle and other metal chelation therapeutics in Alzheimer disease. Biochim Biophys Acta 1741:246\u2013252","journal-title":"Biochim Biophys Acta"},{"key":"9360_CR79","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(02)08695-6","volume":"359","author":"MA Smith","year":"2002","unstructured":"Smith MA, Atwood CS, Joseph JA et al (2002) Predicting the failure of amyloid-beta vaccine. Lancet 359:1864\u20131865","journal-title":"Lancet"},{"key":"9360_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1297.001","volume":"1019","author":"HG Lee","year":"2004","unstructured":"Lee HG, Casadesus G, Zhu X et al (2004) Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann NY Acad Sci 1019:1\u20134","journal-title":"Ann NY Acad Sci"},{"key":"9360_CR81","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","volume":"37","author":"D Kaur","year":"2003","unstructured":"Kaur D, Yantiri F, Rajagopalan S et al (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson\u2019s disease. Neuron 37:899\u2013909","journal-title":"Neuron"},{"key":"9360_CR82","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny RA, Atwood CS, Xilinas ME et al (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron 30:665\u2013676","journal-title":"Neuron"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-007-9360-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-007-9360-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-007-9360-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T21:23:35Z","timestamp":1628889815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-007-9360-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,17]]},"references-count":82,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,17]]}},"alternative-id":["9360"],"URL":"https:\/\/doi.org\/10.1007\/s11064-007-9360-7","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,17]]}}}